we're still on the samsung deal? That's older than dirt, you know the truth there, it's all good, Nader did that for Cytodyn.
As far as OWS goes, I bet cytodyn takes the UK funding as opposed to OWS. It's simple, approval in the UK with a sweet funding deal, that's why they backed out of OWS. If you read between the lines, Leronlimab is good to go with the UK, just working the bugs and legal BS out..you'll see
News 
Market Data 
Discover 
